학술논문
Myeloma Developing Regimens Using Genomics (MyDRUG): Longitudinal Single-Cell Transcriptional Landscape of the Myeloma and Immune Microenvironment in Relapsed/Refractory Multiple Myeloma Patients Treated with MEK-Inhibitor, Cobimetinib
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:7090-7091
Subject
Language
ISSN
0006-4971